Chewy Stock Drops 11%: Time to Buy or Avoid?
💡 Key Takeaway
Chewy's latest earnings reveal a mature business with slowing organic growth, making the stock a risky bet despite its seemingly cheap valuation.
Chewy's Q2 Earnings: What Happened
Chewy (CHWY) reported second-quarter revenue of $3.33 billion, up 7.3% year-over-year and slightly above estimates. However, excluding recent acquisitions, revenue grew just 5.7%. Gross margin held steady at 30.4%, and adjusted EPS came in at $0.36, matching expectations.
Despite meeting estimates, the stock fell 11% on Wednesday. The drop came after management noted on the earnings call that consumer demand remains sluggish, with continued pressure on discretionary spending and premiumization.
Chewy also raised its full-year revenue guidance to $13.46-$13.57 billion, implying 6.8%-7.7% growth, and lifted its adjusted EBITDA margin outlook. But the guidance hike was largely driven by acquisitions, not the core business.
Autoship sales continued to grow, reaching 84.6% of total sales, which provides stability but limits opportunities for one-off purchases that could drive growth. The pet industry has struggled since the pandemic, and Chewy's growth has significantly slowed.
What This Means for Me
Why This Matters for Investors
Chewy was once valued as a high-growth disruptor, but its growth trajectory has flattened. The company now resembles a mature consumer staples stock, with limited room for market share gains in a saturated pet market.
The stock is down 50% from its 52-week high, and while it trades at a forward P/E of 13 on adjusted earnings, that metric is flattered by adjustments like share-based compensation. On a GAAP basis, the P/E is a more average 25.
Investors are concerned that Chewy's best days of rapid growth are behind it. The company's ability to drive organic growth, rather than relying on acquisitions, remains uncertain.
Without a clear catalyst for faster growth, the stock may continue to languish. The weak consumer discretionary environment adds further pressure, as pet owners may cut back on premium products and extras.
Stock to Watch
| Stocks | Impact | Analysis | |
|---|---|---|---|
| CHWY | Negative | Chewy's core business is slowing, and the stock's valuation is less attractive than it appears on an adjusted basis. The company's transition to a mature staples stock may limit upside. | |
| PG | Neutral | Procter & Gamble is mentioned as a comparison for Chewy's shift to a slower-growth consumer staples profile. P&G's stable business model contrasts with Chewy's growth challenges. |
Source: The Motley Fool
Analysis generated by Bobby AI quantitative model, reviewed and edited by our research team. This is not financial advice. Always do your own research before making investment decisions.
Bobby Insight

Avoid Chewy stock until it can demonstrate faster organic growth and a clearer path to sustainable earnings.
Chewy's growth is increasingly reliant on acquisitions, and its core business is maturing. The stock's adjusted valuation masks a more expensive GAAP P/E, and consumer demand remains weak. Better opportunities exist elsewhere in the market.
What This Means for Me

Read More
Procter & Gamble: Strong Sales, Weak Earnings—Buy Now or Wait?
Neutral P&G's sales are accelerating, but margin pressures and a recent rally have left little margin of safety—wait for a better entry point.
PGOct 23, 2026Regeneron's 36% Growth and Pipeline Promise: Time to Buy REGN?
Bullish Regeneron's strong Q3 2026 results, driven by Dupixent and EYLEA HD, plus a promising genetics pipeline, support a bullish long-term outlook despite increased R&D spending.
REGNOct 31, 2026CNI Q3 2026: 18% EPS Growth, Mexico Expansion, and Operating Leverage
Bullish Canadian National Railway is converting operational efficiency into cash flow growth, with normalized capital spending and strategic Mexico access positioning it for long-term earnings leverage.
CNIUNPOct 31, 2026

